期刊文献+

外周血miRNA作为肿瘤标志物的研究进展 被引量:13

下载PDF
导出
摘要 miRNA是一类长度为20—24个核苷酸的非编码小分子RNA,与靶基因3’端非编码区不完全配对,从而抑制靶基因mRNA的翻译,影响个体发育、细胞凋亡、细胞增殖和分化等生命活动,与肿瘤的发生、转移和耐药等病理进程密切相关。近年来的研究发现,除了组织和细胞中的miRNA,外周血miRNA的表达也表现为显著的肿瘤相关性、组织特异性和表达稳定性,符合肿瘤标志物的要求。本文就外周血miRNA作为肿瘤标志物的研究进展进行综述。
作者 万菁
出处 《肿瘤》 CAS CSCD 北大核心 2009年第6期597-599,共3页 Tumor
  • 相关文献

参考文献2

二级参考文献25

  • 1袁联文,唐伟,李永国,幕内雅敏.脱-γ-羧基凝血酶原:一种有用的血清肝癌标志物[J].中华普通外科杂志,2004,19(8):506-506. 被引量:11
  • 2Chaur-Shine Wang,Chin-Lin Lin,Hsi-Chang Lee,Kuan-Yang Chen,Ming-Feng Chiang,Hung-Sheng Chen,Tsung-Jung Lin.Usefulness of serum des-γ-carboxy prothrombin in detection of hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(39):6115-6119. 被引量:19
  • 3Amal Gad,Eiji Tanaka,Akihiro Matsumoto,Moushira Abd-el Wahab,Abd el-Hamid Serwah,Fawzy Attia,Khalil Ali,Howayda Hassouba,Abd el-Raoof el-Deeb,Tetsuya Ichijyo,Takeji Umemura,Hidetomo Muto,Kaname Yoshizawa,Kendo Kiyosawa.Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(42):6607-6612. 被引量:8
  • 4Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 5Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 6Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 7Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 8Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 9Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 10Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.

共引文献1011

同被引文献138

  • 1Wei Liu Sheng-Yong Mao Wei-Yun Zhu.Impact of tiny miRNAs on cancers[J].World Journal of Gastroenterology,2007,13(4):497-502. 被引量:18
  • 2ZHANG H, LI Y, LAI M. The microRNA network and tumor metastasis[J], Oncogene, 2010, 29(7): 937-948.
  • 3OCANA O H, NIETO M A. A new regulatory loop in cancer-cell invasion[J]. EMBO Rep, 2008, 9(6): 521 -522.
  • 4SANTARPIA L, NICOLOSO M, CALIN G A.MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype[J]. Endocr Relat Cancer, 2010, 17(1): F51-75.
  • 5VOORHOEVE P M. MicroRNAs: Oncogenes, tumor suppressors or master regulators of cancer heterogeneity?[J]. Biochim Biophys Acta, 2010, 1805(1): 72-86.
  • 6CHEN G, ZHU W, SHI D, et al. MicroRNA-181a sensitizes human malignant glloma U87MG cells to radiation by targeting Bcl-2[J]. Oncol Rep, 2010, 23(4): 997-1003.
  • 7JI J, YAMASHiTA T, BUDHU A, et al. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells[J]. Hepatology, 2009, 50(2): 472-480.
  • 8MATSUSHIMA K, ISOMOTO H, KOHNO S, et al. MicroRNAs and esophageal squamous cell carcinoma[J]. Digestion, 2010, 82(3): 138-144.
  • 9HU Y, CORREA A M, HOQUE A, et al. Prognostic significance of differentially expressed miRNAs in esophageal cancer[J]. IntJ Cancer, 2011, 128(1): 132-143.
  • 10MATHE E A, NGUYEN G H, BOWMAN E D, et al. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival[J]. Clin Cancer Res, 2009, 15(19): 6192-6200.

引证文献13

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部